Cyclosporin A Reverses Chemoresistance in Patients With Gynecologic Malignancies

Multidrug resistance is a major obstacle in successful systemic therapy of gynecologic malignancies. The objectives of this study are to evaluate the activity of cyclosporin A used to overcome drug resistance in a variety of gynecologic malignancies. Forty women (29 with ovarian cancer, 7 with uteri...

Full description

Bibliographic Details
Main Authors: Anil K. Sood, Joel I. Sorosky, Robert C. Squatrito, Jeffrey S. Skilling, Barrie Anderson, Richard E. Buller
Format: Article
Language:English
Published: Elsevier 1999-06-01
Series:Neoplasia: An International Journal for Oncology Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558699800517

Similar Items